New Findings Show Risk of Zofran Related Heart Defects

As previously noted by filed Zofran lawsuits, new research adds to a growing body of evidence suggesting the risk of Zofran related heart defects in mothers in who took the drug during pregnancy. A study published by Clinical Pharmacology & Therapeutics states that the anti-nausea medication can quickly cross the placenta and remain in the bodies of newborns for an extended period of time.

Attorney Group is currently offering free consultations to women who took Zofran during pregnancy and gave birth to a child with a heart defect. We can answer your questions, and if you have a case, we can connect you with an affiliated Zofran birth defect attorney who can help you seek the compensation to which you may be entitled.

Study Finds Zofran Can Cross Zofran Related Heart Defects

Researchers examined plasma samples from 40 pregnant women and 20 non-pregnant women. While Zofran is only approved for the treatment of vomiting and nausea in surgery or chemotherapy patients, it is commonly promoted for “off-label” use as a morning sickness medication for expecting mothers.

Researchers took samples from umbilical cord blood as well as from the infants after birth and found that the Zofran use by the pregnant women was characterized by rapid transfer through the placenta as well as a longer elimination half-life (the time it takes for the drug in the plasma to reduce by half) in newborns compared to their mothers. Other studies also suggest that the anti-nausea drug crosses the placenta, and researchers in Hong Kong raised concerns in a report published in 2006 in Clinical Pharmacokinetics.

In that study, 41 women were given three doses of Zofran prior to the procedure. Zofran was found in all samples, with a higher-than-expected drug concentration in fetal tissue, leading researchers to call for additional studies at that time.

Following reports involving Zofran heart defects, cleft lip and palate, as well as other birth defects, Zofran birth defect lawsuits have been filed on behalf of babies and children, alleging that the manufacturer neglected to adequately warn about the risks associated with the use of Zofran during pregnancy.

Contact Attorney Group with Questions About Zofran Related Heart Defects

If you took Zofran during pregnancy and your baby was born with heart defects, cleft lip or cleft palate, or another birth defect, contact Attorney Group for more information about your options. At no out-of-pocket cost to you, we can answer your questions. If you have a case, we can connect you with an affiliated Zofran attorney who can assist you throughout the legal process.